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Overexpression of SIRT3 disrupts
mitochondrial proteostasis and cell cycle
progression
Dear Editor,
As a mitochondrial deacetylase, SIRT3 deacetylates many
enzymes involved in central metabolism and maintains
mitochondrial proteostasis (Verdin et al., 2010; Papa and
Germain, 2014). Substrates of SIRT3 include components of
the respiratory complexes, proteins involved in fatty acid
oxidation and TCA cycle (Yu et al., 2012). SIRT3 activates
MnSOD to maintain reactive oxygen species (ROS) home-
ostasis and a loss of SIRT3 contributes to the age-associ-
ated diseases (McDonnell et al., 2015; Qiu et al., 2010).
SIRT3 plays dual roles functioning as a tumor suppressor or
a promoter in tumorigenesis and progression (Alhazzazi
et al., 2011). On one hand, SIRT3 regulates the cellular ROS
level and maintains genomic stability, and mediates meta-
bolic reprogramming to prevent tumorigenesis (Finley and
Haigis, 2012). As a result, the low expression of SIRT3 has
been found in breast cancer, glioblastoma, colon cancer,
osteosarcoma, prostate, and ovarian cancers (Kim et al.,
2010; Finley and Haigis, 2012). On the other hand, SIRT3 is
a prosurvival factor that modulates p53 activities and is
upregulated in oral cancer, the node-positive breast cancer,
and bladder cancer (Ashraf et al., 2006; Alhazzazi et al.,
2011). These results suggest that SIRT3 possesses the
tumor-type dependent function and its precise role needs to
be elucidated in the context of a speciﬁc cancer. Clear cell
renal cell carcinoma (ccRCC) is the most common histo-
logical subtype of renal cancer (Cohen and McGovern,
2005). The aims of the present study were to examine the
expression of SIRT3 in ccRCC and to characterize effects of
SIRT3 on tumorigenesis and progression using 293T human
embryonic kidney cells as the model system that has cancer
stem cell-like features (Debeb et al., 2010).
Equal amounts of proteins extracted from 18 paired
ccRCC lesions and associated pericarcinous tissue samples
were analyzed by Western blotting and the representative
Western blot images of eight paired samples were shown in
Fig. 1A, indicating that the expression levels of SIRT3 were
lower in ccRCC than those in normal tissues. The gray scale
analysis of the Western blot data for all eighteen paired
samples showed that the SIRT3 expression was statistically
down-regulated in ccRCC tissues (Fig. 1B), suggesting that
the low expression of SIRT3 is important for ccRCC
progression.
To understand the role of SIRT3 in tumorigenesis and
progression of ccRCC, stable cells overexpressing SIRT3
were established in 293Tcells. The overexpression of SIRT3
in 293T cells (SIRT3-OE) was examined by Western blotting
(Fig. S1), conﬁrming that the expression level of SIRT3 in
SIRT3-OE cells was four fold higher than that in control cells.
The SIRT3 overexpression in 293T led to a decrease in
proliferation rates (Fig. 1C). The ROS level in SIRT3-OE
cells is two and half fold higher than that in the control cells
as detected using the CellROX® Deep Red kit (Fig. 1D). To
determine the susceptibility of SIRT3-OE cells to oxidative
stress, cells were treated with various concentrations of
hydrogen peroxide for 12 h. The cell viability was measured
using CCK-8 assay. The effects of hydrogen peroxide were
represented as the percentage of viable cells after 12 h
treatment (Fig. 1E). When cells were treated with 400 µmol/L
H2O2 for 12 h, the percentages of viable cells were 20% and
90% for the control and SIRT3-OE cells, respectively
(Fig. 1E). This declares that SIRT3-OE cells are more
resistant to H2O2 treatment.
Next, proteomic analysis was carried out on SIRT3-OE
and control cells in biological replicates. Equal amounts of
proteins from SIRT3-OE and the control cells were in-solu-
tion digested and labeled with TMT reagents. The generated
tryptic peptides were fractionated using off-line HPLC and
each fraction was further analyzed by nano-LC-MS/MS.
Differentially expressed proteins were identiﬁed and quanti-
ﬁed using the TMT-based quantiﬁcation. We identiﬁed 7536
proteins in two biological replicates and the false-positive
rate was estimated to be less than 1%. Based on the aver-
age reporter ion ratios (>1.5 or <0.67), 188 proteins were
found to be differentially expressed between SIRT3-OE and
control cells, in which 93 proteins were down-regulated and
95 were up-regulated (Tables S1 and S2). To understand the
biological relevance of the differentially expressed proteins,
the Gene Ontology (GO) was used to cluster differentially
expressed proteins according to their associated biological
processes. The annotations of gene lists are summarized via
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a pie plot based on the functional classiﬁcation from Panther
as shown in Fig. 2A. One hundred and eighty eight differ-
entially expressed proteins participated in a variety of cellular
processes including metabolic process, cellular process, and
cellular component organization process. The primary
metabolic process shows the dominant difference between
SIRT3-OE and the control cells. About 25% of the down-
regulated proteins are classiﬁed as mitochondrial proteins,
indicating that SIRT3 overexpression has a great impact on
the mitochondrial protein expressions. Five subunits of res-
piratory complex IV were down-regulated in SIRT3-OE cells
including COX7C, COX6A1, COX7A2, COA7, and COA5
(Fig. 2B), suggesting that the SIRT3 overexpression dis-
rupted the integrity of the respiratory complexes. We also
identiﬁed that three proteins in the fatty acid β-oxidation
pathway were downregulated in SIRT3-OE cells including
enoyl-CoA hydratase, very long-chain speciﬁc acyl-CoA
dehydrogenase and hydroxyacyl-coenzyme A dehydroge-
nase. More importantly, proteomic analysis showed that nine
cFigure 2. Proteomic, qPCR and Western blot analysis
of differentially expressed proteins between SIRT3-OE
and control cells. (A) GO analysis of the differentially
expressed proteins in SIRT3-OE cells compared to the
control cells with PANTHER (http://www.pantherdb.org).
(B) Graphical representation of TMT ratios for proteins in
SIRT3-OE cells compared to control cells. (C) qPCR
analysis of mRNA expressions of selected mitochondrial
ribosomal genes and other selected genes from SIRT3-OE
cells and control cells. (D) Western blot analysis of
selected proteins from SIRT3-OE and control cells. (E) Cell
cycle analysis of SIRT3-OE cells and the control cells.
(F) Western blotting images showing expression level of
SIRT3 in HSP60-KN cells compared to the control cells,
WCL (whole cell lysates), Mito (mitochondria); and
(G) mRNA expression level of SIRT3 in HSP60-KN cells
and control cells. Data were analyzed using student’s t-
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Figure 1. Downregulation of SIRT3 in ccRCC compared to associated pericarcinous tissues and characterization of SIRT3
overexpression cells. (A) Representative Western blot images of the expression levels of SIRT3 of eight paired samples, N
(pericarcinous tissue), C (ccRCC tissue). (B) The gray scale analysis of SIRT3 presented in (A). (C) Growth curve of SIRT3-OE and
the control cells. (D) Graphical representation of ROS levels of SIRT3-OE cells compared to the control cells. and (E) Survival rate of
SIRT3-OE cells and the control cells treated with different concentration of H2O2 for 12 h. Data were analyzed using student’s t-test.
*P < 0.05, **P < 0.01 and ***P < 0.001. *P < 0.05 is considered statistically signiﬁcant. Error bars represent ±SEM.
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subunits of mitochondrial ribosomes were downregulated in
SIRT3-OE cells (Fig. 2B). All these results indicated that
SIRT3-overexpression disrupted mitochondrial proteostasis
and contributed to mitochondrial dysfunction.
qPCR analysis was conducted and showed that the
mRNA expression levels of these nine mitochondrial ribo-
somal genes were lower in SIRT3-OE cells than those in the
control cells (Fig. 2C). qPCR analysis also conﬁrmed the
downregulation of other genes including SDHB, COA7,
CDK1, and CDK4 (Fig. 2C). Additionally, Western blotting
was employed to examine expressions of the selected pro-
teins and showed that the expression levels of EEF1A2,
CDK1, and CDK4 were down-regulated whereas those of
vimentin and angiomotin were upregulated in SIRT3-OE
cells (Fig. 2D), consistent with the proteomic results dis-
played in Tables S1 and S2. The above results also showed
that SIRT3-OE cells grew slower than the control cells
(Fig. 1C), indicating that cell cycle progression varies
between those two cells. Indeed, the cell cycle analysis of
SIRT3-OE and control cells showed that SIRT3-OE cells had
the higher G1-phase accumulation (Fig. 2E), in consistent
with the down-regulation of CDK1 and CDK4 in SIRT3-OE
cells.
SIRT3 is known to play a crucial role in maintenance of
mitochondrial proteostasis. Proteomic analysis showed that
multiple subunits of respiratory complex IV were down-reg-
ulated in SIRT3-OE cells, which compromised the integrity
and assembly of respiratory complexes, leading to over-
production of ROS (Fig. 1D). Excessive ROS can negatively
regulate cell growth and may activate the Nrf2/Keap1 path-
way that protects SIRT3-OE cells from oxidative stress
(Fig. 1E). An alternative explanation for the high resistance
to oxidative stress exhibited in SIRT3-OE cells is that
deacetylation of antioxidant proteins by SIRT3 enhances
their enzymatic activities, which needs to be conﬁrmed in the
future study. Three key proteins in fatty acid β-oxidation
pathway were also down-regulated in SIRT3-OE cells
(Table S2). Growth and proliferation of tumor cells require
fatty acids for synthesis of membranes and signaling mole-
cules. Disruption of fatty acid oxidation pathway causes a
decrease in both acetyl-CoA production that is essential for
the de novo lipid synthesis and NADH and FADH2 genera-
tion that are important for ATP and citrate production (Car-
racedo et al., 2013). Moreover, SIRT3-meidated disruption of
fatty acid β-oxidation can lead to the accumulation of fatty
acids to induce lipotoxicity. Cyclin-dependent kinase 1
(CDK1) and cyclin-dependent kinase 4 (CDK4) were found
to be downregulated in SIRT3-OE cells as conﬁrmed by
qPCR and Western blotting. CDK4 is associated with D-type
cyclins to promote cell-cycle entry and progression through
G1 by inactivating the retinoblastoma protein Rb (Sherr and
Roberts, 1999). SIRT3-induced CDK4 downregulation
causes the prolonged G1 cell cycle arrest that contributes to
the slower growth of SIRT3-OE cells as compared to the
control cells.
To further identify factors that regulate SIRT3 stability, we
isolated the SIRT3 complexes from SIRT3-OE cells. Protein
components of the SIRT3 complexes were separated on a
1D SDS-PAGE gel and changes in band intensities were
identiﬁed between SIRT3-OE and the control cells (Fig. S2).
These bands were excised, digested by trypsin and ana-
lyzed by LC-MS/MS, resulting in the identiﬁcation of HSP60
as the major binding partner of SIRT3. Similarly, immuno-
precipitation of HSP60 from 293T cells was carried out and
showed that SIRT3 bound to HSP60, suggesting that SIRT3
directly interacts with HSP60. In order to conﬁrm that HSP60
regulates SIRT3 stability, we established the HSP60
knockdown cells. Western blotting showed that SIRT3 was
down regulated in HSP60 knockdown cells as compared to
the control cells (Fig. 2F). On the other hand, qPCR analysis
revealed that the SIRT3 mRNA level was unchanged
between these two cells, suggesting that HSP60 regulated
SIRT3 stability (Fig. 2G). This is consistent with an early
study showing that two murine SIRT3 isoforms interacted
with HSP60 (Yang et al., 2011). HSP60 is the major mito-
chondrial chaperone and is essential in maintenance of
mitochondrial proteostasis. More work is needed to examine
the molecular mechanisms of SIRT3 degradation in HSP60-
knockdown cells. Nevertheless, our results propose that
HSP60 is important in the maintenance of SIRT3 protein
stability.
Taken together, we demonstrate that SIRT3 overexpres-
sion disrupts mitochondrial proteostasis that causes over-
production of ROS and the cell cycle arrest to suppress cell
proliferation, proposing that the low level expression of
SIRT3 is important for tumorigenesis and progression in
ccRCC. Our data also show that HSP60 mediates the sta-
bility of SIRT3 and proteomics is a powerful approach to
decipher the complex cellular processes.
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